Study of the Effect of 12-week Dietary Supplementation With a Multicomponent Nutritional Supplement on Nails and Skin
NCT ID: NCT05100680
Last Updated: 2021-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2019-11-25
2020-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multicomp group
Food supplement - 2 capsules / day containing together: 20 mg coenzyme Q10,500 mg methyl sulfonyl methane (MSM), 100 mg L-proline, 10 mg L-cysteine (as HCl monohydrate), 2 mg thiamine , 2.4 mg riboflavin, 19 mg niacin, 8.5 mg pantothenic acid, 2.3 mg vitamin B6, 0.15 mg, biotin, 0.0125 mg vitamin B12, 80 mg vitamin C, 5.5 mg vitamin A , 22 mg vitamin E, 10 mg zinc, 0.07 mg selenium, 1.1 mg copper.
Multicomp
Daily dietary supplementation over 12 weeks with test product: food supplement - 2 capsules / day containing together: 20 mg coenzyme Q10,500 mg methyl sulfonyl methane (MSM), 100 mg L-proline, 10 mg L-cysteine (as HCl monohydrate), 2 mg thiamine , 2.4 mg riboflavin, 19 mg niacin, 8.5 mg pantothenic acid, 2.3 mg vitamin B6, 0.15 mg, biotin, 0.0125 mg vitamin B12, 80 mg vitamin C, 5.5 mg vitamin A , 22 mg vitamin E, 10 mg zinc, 0.07 mg selenium, 1.1 mg copper.
Placebo group
Placebo - 2 capsules / day containing modified starch
Placebo
Daily dietary supplementation over 12 weeks with placebo product: dietary supplement - 2 capsules / day, containing only modified starch.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multicomp
Daily dietary supplementation over 12 weeks with test product: food supplement - 2 capsules / day containing together: 20 mg coenzyme Q10,500 mg methyl sulfonyl methane (MSM), 100 mg L-proline, 10 mg L-cysteine (as HCl monohydrate), 2 mg thiamine , 2.4 mg riboflavin, 19 mg niacin, 8.5 mg pantothenic acid, 2.3 mg vitamin B6, 0.15 mg, biotin, 0.0125 mg vitamin B12, 80 mg vitamin C, 5.5 mg vitamin A , 22 mg vitamin E, 10 mg zinc, 0.07 mg selenium, 1.1 mg copper.
Placebo
Daily dietary supplementation over 12 weeks with placebo product: dietary supplement - 2 capsules / day, containing only modified starch.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* rough surface of the nail plate or presence of keratin granulation (trachyonychia)
* lamellar stratification - horizontal layering / peeling (onychoschizia)
* longitudinal stratification or splitting of the distal edge, rupture (onychorrhexis)
* generally healthy
* willingness to participate in research
* signed statement of conscious and free consent to research - informed consent
* willingness not to use any dietary supplements with the active substances contained in the test product (CoQ10, biotin, niacin, vitamin C, β-carotene, vitamin E, zinc, selenium, copper, MSM, L-cysteine, L- proline), other than those to be allocated by researchers
* willingness to follow all research procedures, including participation in all study visits and keeping a diary during the testing of preparations
Exclusion Criteria
* menopause
* pregnancy, lactation
* in the past, surgery on the index finger / middle finger / ring finger of the right hand
* Disorders and deformities of the index finger, middle finger and ring finger of the right hand due to a malformation of the underlying bone, which would interfere with the evaluation of photographs or changes in the nails
* the presence of raised nails from the nail bed (onycholysis) on the index finger, middle finger and ring finger of the right hand
* supplementing the diet with dietary supplements containing CoQ10, biotin and other ingredients of the test product in the last three months before inclusion
* special eating habits used by a small part of the population (veganism, LCHF, calorie-restricted diets)
* diets prescribed by the medical profession
* uncontrolled metabolic and endocrine diseases
* Chronic dermatoses e.g. psoriasis, ichthyosis, various types of dermatitis, lichen planus, alopecia areata, scleroderma
* systemic diseases such as SLE, DLE, diabetes, neuropathy, peripheral artery disease
* have a known or suspected genetic condition that affects the nails (eg Darier's disease, nail patella syndrome, tuberculous sclerosis)
* the presence of anemia
* mental eating disorders
* mental incapacity that prevents proper understanding or cooperation
* sawing the surface of the nail plate or. polishing it in the last 6 months before inclusion and during the study
* any type of manicure involving gelling, artificial nails in the last 6 months before inclusion and during the study
* any type of classic manicure in the last month before inclusion and during the study
* change in the nail and hand care routine in the last month before inclusion and during the study
* change of dietary habits or dietary supplementation in the last 3 months before inclusion and during the study
* infections of the hands and nails on the hands (fungal, bacterial, viral)
* biting fingernails or cuticles
* mechanical irritation and damage to the nails,
* repeated prolonged exposure of the hands to water or repeated use of hand sanitizers,
* use of antimetabolites, retinoids, statins, antiretroviral drugs, fungicides in the last 3 months before inclusion and during the study
* changes in the use of hormonal preparations in the last 6 months before inclusion and during the study
18 Years
76 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Education, Science and Sport of Republic of Slovenia
UNKNOWN
European Regional Development Fund
OTHER
Slovenian Research Agency
OTHER
VIST - Faculty of Applied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katja Zmitek, PhD
Role: STUDY_DIRECTOR
Visoka sola za storitve
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Visoka sola za storitve
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VIST F4F MULTIK 01-2019
Identifier Type: -
Identifier Source: org_study_id